Impax Asset Management Group PLC Eli Lilly & CO Transaction History

Impax Asset Management Group PLC

$22.9 Billion
Q2 2024

A detailed history of Impax Asset Management Group PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Impax Asset Management Group PLC holds 21,961 shares of LLY stock, worth $20 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

21,961

Previous 27,888 21.25%

Holding current value

$20 Million

Previous $21.7 Million 8.35%

% of portfolio

0.09%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $4.3 Million - $5.39 Million	-5,927 Reduced 21.25%	21,961 $19.9 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $1.41 Million - $1.89 Million	-2,380 Reduced 7.86%	27,888 $21.7 Million
Q4 2023 Jan 26, 2024	BUY	$525.19 - $619.13 $819,296 - $965,842	1,560 Added 5.43%	30,268 $17.6 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $948,080 - $1.31 Million	-2,181 Reduced 7.06%	28,708 $15.4 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $27,708 - $37,049	79 Added 0.26%	30,889 $14.5 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $426,494 - $500,897	-1,373 Reduced 4.27%	30,810 $10.6 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $1.31 Million - $1.53 Million	-4,089 Reduced 11.27%	32,183 $11.8 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $402,026 - $458,151	-1,356 Reduced 3.6%	36,272 $11.7 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $160,269 - $188,180	-575 Reduced 1.51%	37,628 $12.2 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $377,616 - $469,280	-1,609 Reduced 4.04%	38,203 $10.9 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $328,955 - $408,235	-1,463 Reduced 3.54%	39,812 $11 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $16,620 - $20,453	75 Added 0.18%	41,275 $9.54 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $722 - $934	-4 Reduced 0.01%	41,200 $9.46 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $2.48 Million - $3.21 Million	15,089 Added 57.78%	41,204 $7.7 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $1.06 Million - $1.41 Million	-8,160 Reduced 23.81%	26,115 $4.41 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $1.64 Million - $1.89 Million	11,184 Added 48.43%	34,275 $5.07 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $68,073 - $81,925	499 Added 2.21%	23,091 $3.79 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $428,341 - $530,165	3,598 Added 18.94%	22,592 $3.13 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $179,411 - $222,217	1,678 Added 9.69%	18,994 $2.5 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $152,068 - $165,411	1,424 Added 8.96%	17,316 $1.94 Million
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $46,088 - $53,797	416 Added 2.69%	15,892 $1.76 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $16 Million - $18.8 Million	-143,318 Reduced 90.25%	15,476 $2.01 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $2.83 Million - $3.17 Million	-26,721 Reduced 14.4%	158,794 $18.4 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $15.9 Million - $19.9 Million	185,515 New	185,515 $19.9 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Account

Impax Asset Management Group PLC Eli Lilly & CO Transaction History